OpenAlex
PricingAboutJobs
Log inGet started
Work

Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.

PubMed

Year: 2003
Type: article
Source: PubMed
Authors: Ilka B Schiffer, Susanne Gebhard, Carolin K Heimerdinger, Annette Heling, Jochem Hast, Ursula Wollscheid, Barbara Seliger, Berno Tanner, Sandra Gilbert, Thomas Beckers, Silke Baasner, Walburgis Brenner, Christian Spangenberg, Dirk Prawitt, Tatjana Trost, Wolfgang G Schreiber, Bernhard Zabel, Manfred Thelen, Hans-Anton Lehr, Franz Oesch, Jan G Hengstler
Institution: Johannes Gutenberg University Mainz
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: HER2/neu, anhydrotetracycline, conditional gene expression, tumor growth inhibition, tumor remission, apoptosis, tumor size dependence, HER2 overexpression, breast cancer, ovarian cancer, receptor tyrosine kinase, tumor recurrence, nude mice, gene silencing
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1574405077
FWCI: 2.991
Cites: 48
Cited by: 48
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security